Skip to the main content

Alcoholism and psychiatry research : Journal on psychiatric research and addictions, Vol. 50 No. 2, 2014.

Original scientific paper

Anxiety and depression in opiate addicts treated with methadone and buprenorphine

Martina Šimunović ; University of Mostar, Faculty of Health Studies, Mostar, Bosnia and Herzegovina
Marko Martinac orcid id orcid.org/0000-0001-9144-6427 ; University of Mostar, Faculty of Health Studies, Mostar, Bosnia and Herzegovina, Mental health center, Mostar, Bosnia and Herzegovina
Marija Dragić ; University of Mostar, Faculty of Health Studies, Mostar, Bosnia and Herzegovina
Milenko Bevanda ; University of Mostar, Faculty of Health Studies, Mostar, Bosnia and Herzegovina
Dragan Babić ; University of Mostar, Faculty of Health Studies, Mostar, Bosnia and Herzegovina,Department of Psychiatry, University Hospital, Mostar, Bosnia and Herzegovina

Full text: english pdf 228 Kb

page 123-137

downloads: 680

cite

Abstract

Objective: To examine anxiety and depression in opiate addicts
treated with methadone and buprenorphine. Subjects and methods:
The study was conducted in the Association 'Margina' and the Center
for Prevention and Out-patient Treatment of Addiction Diseases in Mostar. It included 100 patients who were divided into two groups: the first group consisted of drug subox- on users (N=50) and the other group consisted of subjects addicted to methadone, which was divided into two subgroups: M+ and M– (recurrent). For the purposes of the research, Beck 's Anxiety and Depression Scale, Selfassessment Questionnaire for Anxiety (STAI), socio-demographic questionnaire specifically made for this research and Health Survey SF -36 (Short – Form Health Survey – 36th) were used. Results:
Significantly higher numbers of addicts were living in the city (p =
0.034). The recurrent methadone users were significantly more depressed (> 20 %), while this percentage was somewhat lower in SBX users and M + subjects (20%). There was no statistically significant difference between the latter two groups (p=0.216). SBX users displayed most anxiety (10 %), while it was lowest among the users of methadone (<10 %). There was a statistically significant difference between the users of methadone M+ and M– (p = 0.034). Conclusion: Users of methadone were significantly more anxious than the drug buprenorphine users, while there were no statistically significant differences between the groups considering the depression

Keywords

opiate addicts; anxiety; depression; methadone; buprenorphine

Hrčak ID:

147860

URI

https://hrcak.srce.hr/147860

Publication date:

15.12.2014.

Visits: 1.864 *